EPCAM and neoplasm: EpCAM is now recognized as one of the most studied tumor-associated antigens and has developed into a well-established marker for epithelial cells utilized in pathological examinations of various cancers (Baeuerle and Gires, 2007; de Gouw et al., 2020; Romeu et al., 2013).